1887

Journal of General Virology header logo

Volume 95, Issue 7

Nuclear receptor 4 group A member 1 determines hepatitis C virus entry efficiency through the regulation of cellular receptor and apolipoprotein E expression Free

Abstract

Orphan nuclear receptor subfamily 4 group A member 1 (NR4A1) is a transcription factor stimulated by many factors and plays pivotal roles in metabolism, proliferation and apoptosis. In this study, the expression of NR4A1 in Huh7.5.1 cells was significantly upregulated by hepatitis C virus (HCV) infection. The silencing of NR4A1 inhibited the entry of HCV and reduced the specific infectivity of secreted HCV particles but had only minor or no effect on the genome replication and translation, virion assembly and virus release steps of the virus life cycle. Further experiments demonstrated that the silencing of NR4A1 affected virus entry through pan-downregulation of the expression of HCV receptors scavenger receptor BI, occludin, claudin-1 and epidermal growth factor receptor but not CD81. The reduced specific infectivity of HCV in the knockdown cells was due to decreased apolipoprotein E (ApoE) expression. These results explain the delayed spread of HCV in NR4A1 knockdown Huh7.5.1 cells. Thus, NR4A1 plays a role in HCV replication through regulating the expression of HCV receptors and ApoE, and facilitates HCV entry and spread.

  • Received:
  • Accepted:
  • Published Online:
© 2014 The Authors
Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.065003-0
2014-07-01
2024-04-19
Loading full text...

Full text loading...

/deliver/fulltext/jgv/95/7/1510.html?itemId=/content/journal/jgv/10.1099/vir.0.065003-0&mimeType=html&fmt=ahah

References

  1. André P., Komurian-Pradel F., Deforges S., Perret M., Berland J. L., Sodoyer M., Pol S., Bréchot C., Paranhos-Baccalà G., Lotteau V. 2002; Characterization of low- and very-low-density hepatitis C virus RNA-containing particles. J Virol 76:6919–6928 [View Article][PubMed]
     [Google Scholar]
  2. Benga W. J., Krieger S. E., Dimitrova M., Zeisel M. B., Parnot M., Lupberger J., Hildt E., Luo G., McLauchlan J.other authors 2010; Apolipoprotein E interacts with hepatitis C virus nonstructural protein 5A and determines assembly of infectious particles. Hepatology 51:43–53 [View Article][PubMed]
     [Google Scholar]
  3. Borawski J., Troke P., Puyang X., Gibaja V., Zhao S., Mickanin C., Leighton-Davies J., Wilson C. J., Myer V.other authors 2009; Class III phosphatidylinositol 4-kinase alpha and beta are novel host factor regulators of hepatitis C virus replication. J Virol 83:10058–10074 [View Article][PubMed]
     [Google Scholar]
  4. Camus G., Herker E., Modi A. A., Haas J. T., Ramage H. R., Farese R. V. Jr, Ott M. 2013; Diacylglycerol acyltransferase-1 localizes hepatitis C virus NS5A protein to lipid droplets and enhances NS5A interaction with the viral capsid core. J Biol Chem 288:9915–9923 [View Article][PubMed]
     [Google Scholar]
  5. Chang C., Kokontis J., Liao S. S., Chang Y. 1989; Isolation and characterization of human TR3 receptor: a member of steroid receptor superfamily. J Steroid Biochem 34:391–395 [View Article][PubMed]
     [Google Scholar]
  6. Chang K. S., Jiang J., Cai Z., Luo G. 2007; Human apolipoprotein e is required for infectivity and production of hepatitis C virus in cell culture. J Virol 81:13783–13793 [View Article][PubMed]
     [Google Scholar]
  7. Chen X., Zachar V., Chang C., Ebbesen P., Liu X. 1998; Differential expression of Nur77 family members in human T-lymphotropic virus type 1-infected cells: transactivation of the TR3/nur77 gene by Tax protein. J Virol 72:6902–6906[PubMed]
     [Google Scholar]
  8. Chen H. Z., Zhao B. X., Zhao W. X., Li L., Zhang B., Wu Q. 2008; Akt phosphorylates the TR3 orphan receptor and blocks its targeting to the mitochondria. Carcinogenesis 29:2078–2088 [View Article][PubMed]
     [Google Scholar]
  9. Chen H. Z., Wen Q., Wang W. J., He J. P., Wu Q. 2013; The orphan nuclear receptor TR3/Nur77 regulates ER stress and induces apoptosis via interaction with TRAPγ. Int J Biochem Cell Biol 45:1600–1609 [View Article][PubMed]
     [Google Scholar]
  10. Coller K. E., Heaton N. S., Berger K. L., Cooper J. D., Saunders J. L., Randall G. 2012; Molecular determinants and dynamics of hepatitis C virus secretion. PLoS Pathog 8:e1002466 [View Article][PubMed]
     [Google Scholar]
  11. Darragh J., Soloaga A., Beardmore V. A., Wingate A. D., Wiggin G. R., Peggie M., Arthur J. S. 2005; MSKs are required for the transcription of the nuclear orphan receptors Nur77, Nurr1 and Nor1 downstream of MAPK signalling. Biochem J 390:749–759 [View Article][PubMed]
     [Google Scholar]
  12. Evans M. J., von Hahn T., Tscherne D. M., Syder A. J., Panis M., Wölk B., Hatziioannou T., McKeating J. A., Bieniasz P. D., Rice C. M. 2007; Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry. Nature 446:801–805 [View Article][PubMed]
     [Google Scholar]
  13. Francis G. A., Fayard E., Picard F., Auwerx J. 2003; Nuclear receptors and the control of metabolism. Annu Rev Physiol 65:261–311 [View Article][PubMed]
     [Google Scholar]
  14. García-Mediavilla M. V., Pisonero-Vaquero S., Lima-Cabello E., Benedicto I., Majano P. L., Jorquera F., González-Gallego J., Sánchez-Campos S. 2012; Liver X receptor α-mediated regulation of lipogenesis by core and NS5A proteins contributes to HCV-induced liver steatosis and HCV replication. Lab Invest 92:1191–1202 [View Article][PubMed]
     [Google Scholar]
  15. Gastaminza P., Kapadia S. B., Chisari F. V. 2006; Differential biophysical properties of infectious intracellular and secreted hepatitis C virus particles. J Virol 80:11074–11081 [View Article][PubMed]
     [Google Scholar]
  16. Gastaminza P., Cheng G., Wieland S., Zhong J., Liao W., Chisari F. V. 2008; Cellular determinants of hepatitis C virus assembly, maturation, degradation, and secretion. J Virol 82:2120–2129 [View Article][PubMed]
     [Google Scholar]
  17. Gibbons G. F., Islam K., Pease R. J. 2000; Mobilisation of triacylglycerol stores. Biochim Biophys Acta 1483:37–57 [View Article][PubMed]
     [Google Scholar]
  18. Goldwasser J., Cohen P. Y., Lin W., Kitsberg D., Balaguer P., Polyak S. J., Chung R. T., Yarmush M. L., Nahmias Y. 2011; Naringenin inhibits the assembly and long-term production of infectious hepatitis C virus particles through a PPAR-mediated mechanism. J Hepatol 55:963–971 [View Article][PubMed]
     [Google Scholar]
  19. Granberg F., Svensson C., Pettersson U., Zhao H. 2006; Adenovirus-induced alterations in host cell gene expression prior to the onset of viral gene expression. Virology 353:1–5 [View Article][PubMed]
     [Google Scholar]
  20. Han Q., Xu C., Wu C., Zhu W., Yang R., Chen X. 2009; Compensatory mutations in NS3 and NS5A proteins enhance the virus production capability of hepatitis C reporter virus. Virus Res 145:63–73 [View Article][PubMed]
     [Google Scholar]
  21. Herker E., Harris C., Hernandez C., Carpentier A., Kaehlcke K., Rosenberg A. R., Farese R. V. Jr, Ott M. 2010; Efficient hepatitis C virus particle formation requires diacylglycerol acyltransferase-1. Nat Med 16:1295–1298 [View Article][PubMed]
     [Google Scholar]
  22. Hirata Y., Kiuchi K., Chen H. C., Milbrandt J., Guroff G. 1993; The phosphorylation and DNA binding of the DNA-binding domain of the orphan nuclear receptor NGFI-B. J Biol Chem 268:24808–24812[PubMed]
     [Google Scholar]
  23. Hishiki T., Shimizu Y., Tobita R., Sugiyama K., Ogawa K., Funami K., Ohsaki Y., Fujimoto T., Takaku H.other authors 2010; Infectivity of hepatitis C virus is influenced by association with apolipoprotein E isoforms. J Virol 84:12048–12057 [View Article][PubMed]
     [Google Scholar]
  24. Huang H., Sun F., Owen D. M., Li W., Chen Y., Gale M. Jr, Ye J. 2007; Hepatitis C virus production by human hepatocytes dependent on assembly and secretion of very low-density lipoproteins. Proc Natl Acad Sci U S A 104:5848–5853 [View Article][PubMed]
     [Google Scholar]
  25. Hueging K., Doepke M., Vieyres G., Bankwitz D., Frentzen A., Doerrbecker J., Gumz F., Haid S., Wolk B.other authors 2014; Apolipoprotein E co-determines tissue-tropism of hepatitis C virus and it is crucial for viral cell-to-cell transmission by contributing to a post-envelopment step of assembly. J Virol 88:1433–1446 [View Article][PubMed]
     [Google Scholar]
  26. Humphries A., Weller J., Klein D., Baler R., Carter D. A. 2004; NGFI-B (Nurr77/Nr4a1) orphan nuclear receptor in rat pinealocytes: circadian expression involves an adrenergic-cyclic AMP mechanism. J Neurochem 91:946–955 [View Article][PubMed]
     [Google Scholar]
  27. Jiang J., Cun W., Wu X., Shi Q., Tang H., Luo G. 2012; Hepatitis C virus attachment mediated by apolipoprotein E binding to cell surface heparan sulfate. J Virol 86:7256–7267 [View Article][PubMed]
     [Google Scholar]
  28. Katagiri Y., Takeda K., Yu Z.-X., Ferrans V. J., Ozato K., Guroff G. 2000; Modulation of retinoid signalling through NGF-induced nuclear export of NGFI-B. Nat Cell Biol 2:435–440 [View Article][PubMed]
     [Google Scholar]
  29. Kim K. H., Hong S. P., Kim K., Park M. J., Kim K. J., Cheong J. 2007; HCV core protein induces hepatic lipid accumulation by activating SREBP1 and PPARγ. Biochem Biophys Res Commun 355:883–888 [View Article][PubMed]
     [Google Scholar]
  30. Lee M. O., Kang H. J., Cho H., Shin E. C., Park J. H., Kim S. J. 2001; Hepatitis B virus X protein induced expression of the Nur77 gene. Biochem Biophys Res Commun 288:1162–1168 [View Article][PubMed]
     [Google Scholar]
  31. Lee J. M., Lee K. H., Weidner M., Osborne B. A., Hayward S. D. 2002; Epstein–Barr virus EBNA2 blocks Nur77-mediated apoptosis. Proc Natl Acad Sci U S A 99:11878–11883 [View Article][PubMed]
     [Google Scholar]
  32. Lee J. M., Lee K. H., Farrell C. J., Ling P. D., Kempkes B., Park J. H., Hayward S. D. 2004; EBNA2 is required for protection of latently Epstein–Barr virus-infected B cells against specific apoptotic stimuli. J Virol 78:12694–12697 [View Article][PubMed]
     [Google Scholar]
  33. Lin B., Kolluri S. K., Lin F., Liu W., Han Y. H., Cao X., Dawson M. I., Reed J. C., Zhang X. K. 2004; Conversion of Bcl-2 from protector to killer by interaction with nuclear orphan receptor Nur77/TR3. Cell 116:527–540 [View Article][PubMed]
     [Google Scholar]
  34. Lindenbach B. D. 2009; Measuring HCV infectivity produced in cell culture and in vivo. Methods Mol Biol 510:329–336 [View Article][PubMed]
     [Google Scholar]
  35. Lindenbach B. D., Evans M. J., Syder A. J., Wölk B., Tellinghuisen T. L., Liu C. C., Maruyama T., Hynes R. O., Burton D. R.other authors 2005; Complete replication of hepatitis C virus in cell culture. Science 309:623–626 [View Article][PubMed]
     [Google Scholar]
  36. Liu X., Chen X., Zachar V., Chang C., Ebbesen P. 1999; Transcriptional activation of human TR3/nur77 gene expression by human T-lymphotropic virus type I Tax protein through two AP-1-like elements. J Gen Virol 80:3073–3081[PubMed]
     [Google Scholar]
  37. Lupberger J., Zeisel M. B., Xiao F., Thumann C., Fofana I., Zona L., Davis C., Mee C. J., Turek M.other authors 2011; EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy. Nat Med 17:589–595 [View Article][PubMed]
     [Google Scholar]
  38. Maxwell M. A., Muscat G. E. 2006; The NR4A subgroup: immediate early response genes with pleiotropic physiological roles. Nucl Recept Signal 4:e002 [View Article][PubMed]
     [Google Scholar]
  39. Menzel N., Fischl W., Hueging K., Bankwitz D., Frentzen A., Haid S., Gentzsch J., Kaderali L., Bartenschlager R., Pietschmann T. 2012; MAP-kinase regulated cytosolic phospholipase A2 activity is essential for production of infectious hepatitis C virus particles. PLoS Pathog 8:e1002829 [View Article][PubMed]
     [Google Scholar]
  40. Merz A., Long G., Hiet M. S., Brügger B., Chlanda P., Andre P., Wieland F., Krijnse-Locker J., Bartenschlager R. 2011; Biochemical and morphological properties of hepatitis C virus particles and determination of their lipidome. J Biol Chem 286:3018–3032 [View Article][PubMed]
     [Google Scholar]
  41. Miyanari Y., Atsuzawa K., Usuda N., Watashi K., Hishiki T., Zayas M., Bartenschlager R., Wakita T., Hijikata M., Shimotohno K. 2007; The lipid droplet is an important organelle for hepatitis C virus production. Nat Cell Biol 9:1089–1097 [View Article][PubMed]
     [Google Scholar]
  42. Mohd Hanafiah K., Groeger J., Flaxman A. D., Wiersma S. T. 2013; Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology 57:1333–1342 [View Article][PubMed]
     [Google Scholar]
  43. Olejnik-Schmidt A. K., Schmidt M. T., Goździcka-Józefiak A. 2006; Orphan nuclear hormone receptor NR4A1 interacts with HPV16 E2 regulatory protein. Cell Mol Biol Lett 11:102–108 [View Article][PubMed]
     [Google Scholar]
  44. Pei L., Castrillo A., Chen M., Hoffmann A., Tontonoz P. 2005; Induction of NR4A orphan nuclear receptor expression in macrophages in response to inflammatory stimuli. J Biol Chem 280:29256–29262 [View Article][PubMed]
     [Google Scholar]
  45. Pei L., Waki H., Vaitheesvaran B., Wilpitz D. C., Kurland I. J., Tontonoz P. 2006; NR4A orphan nuclear receptors are transcriptional regulators of hepatic glucose metabolism. Nat Med 12:1048–1055 [View Article][PubMed]
     [Google Scholar]
  46. Pei R., Chen H., Lu L., Zhu W., Beckebaum S., Cicinnati V., Lu M., Chen X. 2011; Hepatitis C virus infection induces the expression of amphiregulin, a factor related to the activation of cellular survival pathways and required for efficient viral assembly. J Gen Virol 92:2237–2248 [View Article][PubMed]
     [Google Scholar]
  47. Pekarsky Y., Hallas C., Palamarchuk A., Koval A., Bullrich F., Hirata Y., Bichi R., Letofsky J., Croce C. M. 2001; Akt phosphorylates and regulates the orphan nuclear receptor Nur77. Proc Natl Acad Sci U S A 98:3690–3694 [View Article][PubMed]
     [Google Scholar]
  48. Perlmann T., Jansson L. 1995; A novel pathway for vitamin A signaling mediated by RXR heterodimerization with NGFI-B and NURR1. Genes Dev 9:769–782 [View Article][PubMed]
     [Google Scholar]
  49. Philips A., Lesage S., Gingras R., Maira M. H., Gauthier Y., Hugo P., Drouin J. 1997; Novel dimeric Nur77 signaling mechanism in endocrine and lymphoid cells. Mol Cell Biol 17:5946–5951[PubMed]
     [Google Scholar]
  50. Pileri P., Uematsu Y., Campagnoli S., Galli G., Falugi F., Petracca R., Weiner A. J., Houghton M., Rosa D.other authors 1998; Binding of hepatitis C virus to CD81. Science 282:938–941 [View Article][PubMed]
     [Google Scholar]
  51. Ploss A., Evans M. J., Gaysinskaya V. A., Panis M., You H., de Jong Y. P., Rice C. M. 2009; Human occludin is a hepatitis C virus entry factor required for infection of mouse cells. Nature 457:882–886 [View Article][PubMed]
     [Google Scholar]
  52. Pols T. W., Ottenhoff R., Vos M., Levels J. H., Quax P. H., Meijers J. C., Pannekoek H., Groen A. K., de Vries C. J. 2008; Nur77 modulates hepatic lipid metabolism through suppression of SREBP1c activity. Biochem Biophys Res Commun 366:910–916 [View Article][PubMed]
     [Google Scholar]
  53. Rakic B., Sagan S. M., Noestheden M., Bélanger S., Nan X., Evans C. L., Xie X. S., Pezacki J. P. 2006; Peroxisome proliferator-activated receptor α antagonism inhibits hepatitis C virus replication. Chem Biol 13:23–30 [View Article][PubMed]
     [Google Scholar]
  54. Scarselli E., Ansuini H., Cerino R., Roccasecca R. M., Acali S., Filocamo G., Traboni C., Nicosia A., Cortese R., Vitelli A. 2002; The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus. EMBO J 21:5017–5025 [View Article][PubMed]
     [Google Scholar]
  55. Schinazi R., Halfon P., Marcellin P., Asselah T. 2014; HCV direct-acting antiviral agents: the best interferon-free combinations. Liver Int 34:Suppl 169–78 [View Article][PubMed]
     [Google Scholar]
  56. Sun Z., Cao X., Jiang M. M., Qiu Y., Zhou H., Chen L., Qin B., Wu H., Jiang F.other authors 2012; Inhibition of β-catenin signaling by nongenomic action of orphan nuclear receptor Nur77. Oncogene 31:2653–2667 [View Article][PubMed]
     [Google Scholar]
  57. Tai A. W., Benita Y., Peng L. F., Kim S. S., Sakamoto N., Xavier R. J., Chung R. T. 2009; A functional genomic screen identifies cellular cofactors of hepatitis C virus replication. Cell Host Microbe 5:298–307 [View Article][PubMed]
     [Google Scholar]
  58. Tao W., Xu C., Ding Q., Li R., Xiang Y., Chung J., Zhong J. 2009; A single point mutation in E2 enhances hepatitis C virus infectivity and alters lipoprotein association of viral particles. Virology 395:67–76 [View Article][PubMed]
     [Google Scholar]
  59. Tetradis S., Bezouglaia O., Tsingotjidou A. 2001; Parathyroid hormone induces expression of the nuclear orphan receptor Nurr1 in bone cells. Endocrinology 142:663–670 [View Article][PubMed]
     [Google Scholar]
  60. Thompson J., Winoto A. 2008; During negative selection, Nur77 family proteins translocate to mitochondria where they associate with Bcl-2 and expose its proapoptotic BH3 domain. J Exp Med 205:1029–1036 [View Article][PubMed]
     [Google Scholar]
  61. To S. K., Zeng J. Z., Wong A. S. 2012; Nur77: a potential therapeutic target in cancer. Expert Opin Ther Targets 16:573–585 [View Article][PubMed]
     [Google Scholar]
  62. Tsutsumi T., Suzuki T., Shimoike T., Suzuki R., Moriya K., Shintani Y., Fujie H., Matsuura Y., Koike K., Miyamura T. 2002; Interaction of hepatitis C virus core protein with retinoid X receptor α modulates its transcriptional activity. Hepatology 35:937–946 [View Article][PubMed]
     [Google Scholar]
  63. Wagner M., Zollner G., Trauner M. 2011; Nuclear receptors in liver disease. Hepatology 53:1023–1034 [View Article][PubMed]
     [Google Scholar]
  64. Williams G. T., Lau L. F. 1993; Activation of the inducible orphan receptor gene nur77 by serum growth factors: dissociation of immediate-early and delayed-early responses. Mol Cell Biol 13:6124–6136[PubMed]
     [Google Scholar]
  65. Wilson T. E., Fahrner T. J., Johnston M., Milbrandt J. 1991; Identification of the DNA binding site for NGFI-B by genetic selection in yeast. Science 252:1296–1300 [View Article][PubMed]
     [Google Scholar]
  66. Wilson A. J., Arango D., Mariadason J. M., Heerdt B. G., Augenlicht L. H. 2003; TR3/Nur77 in colon cancer cell apoptosis. Cancer Res 63:5401–5407[PubMed]
     [Google Scholar]
  67. Xu S., Pei R., Guo M., Han Q., Lai J., Wang Y., Wu C., Zhou Y., Lu M., Chen X. 2012; Cytosolic phospholipase A2 gamma is involved in hepatitis C virus replication and assembly. J Virol 86:13025–13037 [View Article][PubMed]
     [Google Scholar]
  68. Yeo M. G., Yoo Y. G., Choi H. S., Pak Y. K., Lee M. O. 2005; Negative cross-talk between Nur77 and small heterodimer partner and its role in apoptotic cell death of hepatoma cells. Mol Endocrinol 19:950–963 [View Article][PubMed]
     [Google Scholar]
  69. Zeng J., Wu Y., Liao Q., Li L., Chen X. 2012; Liver X receptors agonists impede hepatitis C virus infection in an Idol-dependent manner. Antiviral Res 95:245–256 [View Article][PubMed]
     [Google Scholar]
  70. Zhang P., Hu Y., Yang J., Zheng L., Wang Q. 2012; The orphan nuclear receptor Nur77 regulates hepatic cholesterol metabolism through the suppression of LDLR and HMGCR expression. Mol Med Rep 5:1541–1547[PubMed]
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.065003-0
Loading
Nuclear receptor 4 group A member 1 determines hepatitis C virus entry efficiency through the regulation of cellular receptor and apolipoprotein E expression
J. Gen. Virol. 95, 1510 (2014); https://doi.org/10.1099/vir.0.065003-0
/content/journal/jgv/10.1099/vir.0.065003-0
/content/journal/jgv/10.1099/vir.0.065003-0
Loading

Data & Media loading...

Supplements

Supplementary material 1

PDF

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error